About the Organization
The Eureka Institute for Translational Medicine is a fledging organization born out of the founders’ passion for medical innovation and for improving the quality of life for sufferers of chronic, and often under-researched and abandoned, diseases. While the organization is new, it has conducted a Consensus conference with world leaders in medicine to help shape guide its principal goals and activities in accordance with actual gaps in the industry, and not just perceived needs. We believe this effort, in addition to the specific experience of the board and charter members, contributes to our qualifications as an organization.

Presently serving on the Board of Directors are:

• Salvo Albani, M.D., Ph.D., Professor, Director of Translational Research; Infectious and Inflammatory Diseases, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA
• David Hafler, M.D., Ph.D., Chief and Chair of Neurology, Yale New Haven Hospital and Yale School of Medicine
• Janet Hafler, Ed.D., Assistant Dean for Educational Scholarship, Yale School of Medicine
• Juan Carlos Lopez, Ph.D., Editor in Chief, Nature Medicine, New York, New York
• Berent Prakken, M.D., Ph.D., Professor of Pediatric Immunology at the University Medical Centre Utrecht, the Netherlands; Chair, EULAR
• Norman Rosenblum, M.D., Professor of Paediatrics, Canada Research Chair in Developmental Nephrology, and Associate Dean, Physician Scientist Training, University of Toronto
• Vicki Seyfert-Margolis, Ph.D., Food and Drug Administration, Washington, D.C.